Hereditary hemorrhagic telangiectasia is a rare, autosomal dominant genetic disease that causes abnormal growth of blood vessels and, subsequently, life-threatening arteriovenous malformations in vital organs. Epistaxis may be one of the initial clues that a patient has more serious, generalized arteriovenous malformations. Recommended treatment involves careful evaluation to determine the severity and risk of spontaneous rupture of the malformations and the management of various signs and symptoms. The disease remains undiagnosed in many patients, and health care providers may miss the diagnosis until catastrophic events happen in multiple family members. Prompt recognition of hereditary hemorrhagic telangiectasia and early intervention can halt the dangerous course of the disease. Critical care nurses can assist with early diagnosis within families with this genetic disease, thus preventing early death and disability.
Feature| June 01 2016
Hereditary Hemorrhagic Telangiectasia: A Primer for Critical Care Nurses
Kathleen M. Sacco, MSN, ACNP-BC, CCRN, CHPN;
Kathleen M. Sacco is the director, Intensive Care Unit and Cardiopulmonary Services, Simi Valley Hospital, Simi Valley, California.
Corresponding author: Kathleen Sacco, msn, acnp-bc, ccrn, chpn, 2975 Sycamore Dr, Simi Valley, CA 93065 (e-mail: email@example.com).
Search for other works by this author on:
Crit Care Nurse (2016) 36 (3): 36–48.
- Views Icon Views
- Share Icon Share
- Tools Icon Tools
Kathleen M. Sacco, Thomas W. Barkley; Hereditary Hemorrhagic Telangiectasia: A Primer for Critical Care Nurses. Crit Care Nurse 1 June 2016; 36 (3): 36–48. doi: https://doi.org/10.4037/ccn2016270
Download citation file: